Clinical trial management systems: what the system owns against the edc clinical trial platform, how edc clinical trial software and a clinical trial edc selection differ, which clinical trial vendors own which part, and the questions that decide a selection
A clinical trial management system runs the operational side of a study: sites, subjects, visits, monitoring, payments and milestones. It is not the system that collects the clinical data, and confusing the two is how organisations buy overlapping products and end up reconciling them by hand. This page sets out the boundary and what to establish during a selection.
- the FDA rule on electronic records and signatures a regulated lab's system must satisfy
- Part 11
- good laboratory practice for nonclinical studies, 21 CFR
- Part 58
- the ISO/IEC standard testing and calibration labs are accredited against
- 17025
Figures in this panel are the rules a laboratory system of record is bought against, named from the regulations themselves and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and says so rather than implying an index it does not hold.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
The boundary and the selection
- Operations here, clinical data elsewhere. The trial management system tracks whether a visit happened; the electronic data capture platform holds what was recorded at it. Products in both categories extend toward each other, so decide which one is authoritative for each fact before any demonstration.
- Site and subject tracking at the level you work. Confirm the system models your study structure, including multi-country studies, cohorts and amendments, without workarounds. Systems that need a workaround for the study shape you actually run will need one on every study.
- Monitoring, payments and milestones. Visit planning, monitoring reports, site payments against milestones and budget tracking are where the operational value sits. Ask to see a monitoring workflow and a site payment run with realistic data rather than a dashboard.
- Integrations that exist today. Ask what the system integrates with in production at a named customer: the data capture platform, the safety database, the trial master file, finance. Roadmap integrations are not integrations, and the boundaries are where the manual work accumulates.
- Validation and records. Where the system holds records supporting a regulated submission, electronic record and signature obligations apply, along with validation of the configured system. Ask what the vendor provides toward that and what remains yours.
Sizing the purchase to the organisation
A sponsor running a small number of studies has very different needs from one running many across regions, and the enterprise products are configured by specialists over months. Buying an enterprise system for a first study is a common and expensive mismatch.
Ask for reference customers of comparable size and study complexity, and ask them how long implementation actually took against what was quoted.
The trial master file
The essential documents of a trial have to be complete, current and inspection-ready, and whether that lives in the trial management system or a dedicated product is a real decision. Either way, completeness is assessed continuously rather than at the end.
Confirm how the system supports that assessment, because a document repository that cannot tell you what is missing is a folder with a login.
Common questions
- What is a clinical trial management system?
- The operational system of record for a study: sites, subjects, visits, monitoring, payments, milestones and budgets. It tracks whether things happened, rather than holding the clinical data recorded at them.
- Is it the same as electronic data capture?
- No. Data capture holds the clinical data collected at visits; trial management holds the operational picture. Products in both categories extend toward each other, so the authoritative source for each fact must be decided before selection.
- Does the system need validating?
- Where it holds records supporting a regulated submission, yes, along with the electronic records and signatures obligations. Establish what the vendor supplies toward validation and what remains the sponsor's.
- What should I check in a demonstration?
- A monitoring workflow and a site payment run using a study structure like your own, plus integrations that exist in production at a named customer rather than on a roadmap.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/clinical-trial-management/.